TRAW - Latest News

Traws Pharma, Inc. (TRAW), operates in Healthcare / Biotechnology, trades on NASDAQ.

Market capitalization stands near $13.6M. Beta to the broader market is 1.47.

The article list below shows the most recent TRAW headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent TRAW Headlines

Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks

globenewswire.com - May 27, 2026

Broad-spectrum antiviral agent with potential utility against Hantavirus, Ebola and Lassa Utilizing a novel dual-strike mechanism, the proprietary com

Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results

globenewswire.com - May 15, 2026

Private financing of up to $60M offering of common stock (with $10M upfront) and milestone-based warrants expected to support operations into Q1 2027

Traws Pharma Gains After Hantavirus Drug Development Update Amid Cruise Ship Outbreak

benzinga.com - May 8, 2026

Traws Pharma, Inc. (NASDAQ:TRAW) shares are up during Friday's session, trading higher by 25.

Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections

globenewswire.com - May 8, 2026

NEWTOWN, Pa. , May 08, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc.

Traws Pharma, Inc. (TRAW) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

zacks.com - Apr 20, 2026

Traws Pharma, Inc. (TRAW) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart.

How News Affects TRAW Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track TRAW's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked TRAW news questions

What is the latest TRAW news headline?

The most recent TRAW headline (May 27, 2026) is "Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the TRAW news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What TRAW news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual TRAW options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.